In particular, mutations in genes for amyloid precursor protein (APP) and its processing favor increased generation of the pathogenic amyloid-beta 1–42 (Aβ42) peptide and confer susceptibility to early onset AD [2]. This evidence concerns the gene APP and Alzheimer disease.